LivaNova (LIVN) Receives FDA Clearance for 3T Heater-Cooler Device Modification

Go back to LivaNova (LIVN) Receives FDA Clearance for 3T Heater-Cooler Device Modification

LivaNova plc (LIVN) Tops Q4 EPS by 1c, Revenues Miss; Offers FY20 EPS Mid-Point Guidance Below Consensus

February 26, 2020 6:15 AM EST

LivaNova plc (NASDAQ: LIVN) reported Q4 EPS of $1.00, $0.01 better than the analyst estimate of $0.99. Revenue for the quarter came in at $287.6 million versus the consensus estimate of $296.8 million.

We are encouraged by several trends in our fourth quarter 2019 results, highlighted by strong sales in... More